Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children

被引:43
|
作者
Waites, K
Johnson, C
Gray, B
Edwards, K
Crain, M
Benjamin, W
机构
[1] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35233 USA
[2] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35233 USA
[3] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35233 USA
[4] Spartanburg Reg Healthcare Ctr, Spartanburg, SC USA
[5] Vanderbilt Univ, Dept Pediat, Nashville, TN USA
关键词
D O I
10.1128/JCM.38.5.1731-1734.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We studied 198 macrolide-resistant S. pneumoniae isolates obtained from adults and children to evaluate whether 2-mu g clindamycin disks can distinguish between isolates manifesting ermB- versus mefE-mediated resistance to clarithromycin and to determine the relative frequency with which each resistance mechanism occurred in these populations. The mefE gene was predominant among 109 isolates from children, occurring in 73.4% versus 50.6% of 89 isolates from adults. Three isolates (1.5%) did not amplify either gene. Among 125 mefE(+) isolates, the MIC of clarithromycin at which 90% of the isolates tested were inhibited, determined by Etest, was 32 mu g/ml versus >256 mu g/ml in 70 ermB(+) isolates, All ermB(+) isolates were highly resistant to clindamycin (MICs >256 mu g/ml), whereas all mefE(+) isolates were susceptible to clindamycin using the 2-mu g disk. Testing S. pneumoniae from the respiratory tract for susceptibility to clindamycin by agar disk diffusion is an easy and inexpensive method to estimate the frequency of resistance mediated by ermB in specific patient populations, Macrolide resistance mediated by ermB is usually of greater magnitude than that due to mefE. Clinical studies are needed to determine the significance of high- versus low-level macrolide resistance in S. pneumoniae.
引用
收藏
页码:1731 / 1734
页数:4
相关论文
共 50 条
  • [1] Increase of macrolide-resistant Streptococcus pneumoniae -: Expressing mefE or ermB gene in the nasopharynx among children with otitis media
    Hotomi, M
    Billal, DS
    Shimada, J
    Suzumoto, M
    Yamauchi, K
    Fujihara, K
    Yamanaka, N
    LARYNGOSCOPE, 2005, 115 (02): : 317 - 320
  • [2] Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia
    Reinert, Ralf R.
    Filimonova, Olga Y.
    Al-Lahham, Adnan
    Grudinina, Svetlana A.
    Ilina, Elena N.
    Weigel, Linda M.
    Sidorenko, Sergey V.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) : 2260 - 2262
  • [3] Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium
    Van Eldere, J
    Meekers, E
    Lagrou, K
    Massonet, C
    Canu, A
    Devenyns, I
    Verhaegen, J
    Syrogiannopoulos, G
    Leclercq, R
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (04) : 332 - 334
  • [4] Human Antimicrobial Peptide LL-37 Induces MefE/Mel-Mediated Macrolide Resistance in Streptococcus pneumoniae
    Zaehner, Dorothea
    Zhou, Xiaoliu
    Chancey, Scott T.
    Pohl, Jan
    Shafer, William M.
    Stephens, David S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (08) : 3516 - 3519
  • [5] Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and β-lactam resistance, and to detect common macrolide resistance determinants
    Nagai, K
    Shibasaki, Y
    Hasegawa, K
    Davies, TA
    Jacobs, MR
    Ubukata, K
    Appelbaum, PC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (06) : 915 - 918
  • [6] Macrolide and Clindamycin Resistance in Streptococcus milleri Group Isolates from the Airways of Cystic Fibrosis Patients
    Grinwis, Margot E.
    Sibley, Christopher D.
    Parkins, Michael D.
    Eshaghurshan, Christina S.
    Rabin, Harvey R.
    Surette, Michael G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (07) : 2823 - 2829
  • [7] Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA
    Barry, AL
    Fuchs, PC
    Brown, SD
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) : 139 - 140
  • [8] Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece
    Ioanna N Grivea
    Alexia Sourla
    Eleni Ntokou
    Denise C Chryssanthopoulou
    Alexandra G Tsantouli
    George A Syrogiannopoulos
    BMC Infectious Diseases, 12
  • [9] Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America
    Hoban, DJ
    JOURNAL OF CHEMOTHERAPY, 2002, 14 : 25 - 30
  • [10] Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece
    Grivea, Ioanna N.
    Sourla, Alexia
    Ntokou, Eleni
    Chryssanthopoulou, Denise C.
    Tsantouli, Alexandra G.
    Syrogiannopoulos, George A.
    BMC INFECTIOUS DISEASES, 2012, 12